Yayın:
Editorial: Multi-targeted tyrosine kinase inhibitors in the treatment of cancer and neurodegenerative disorders

Sadeleştirilmiş öğe sayfası
dc.contributor.authorBelgin Sever
dc.contributor.authorSEVER, BELGİN
dc.contributor.authorLuciano Saso
dc.contributor.authorRumiana Tzoneva
dc.contributor.authorValentina Onnis
dc.contributor.authorHalil I. Ciftci
dc.contributor.orcid0000-0003-4847-9711
dc.contributor.orcid0000-0003-4530-8706
dc.contributor.orcid0000-0001-6659-2588
dc.contributor.orcid0000-0002-2438-725X
dc.contributor.orcid0000-0002-9796-7669
dc.date.accessioned2025-11-13T12:08:21Z
dc.date.issued2024-07-26
dc.identifier.doihttps://doi.org/10.3389/fchem.2024.1460347
dc.identifier.endpage1460347
dc.identifier.issn2296-2646
dc.identifier.openalexW4401038213
dc.identifier.startpage1460347
dc.identifier.urihttps://hdl.handle.net/11421/9083
dc.identifier.urihttps://doi.org/10.3389/fchem.2024.1460347
dc.identifier.volume12
dc.language.isoen
dc.relation.ispartofFrontiers in Chemistry
dc.rightsopenAccess
dc.subjectTyrosine kinase
dc.subjectProtein-Tyrosine Kinases
dc.subjectCancer research
dc.subjectKinase
dc.subjectMedicine
dc.subjectTyrosine
dc.subjectCancer
dc.subjectBiology
dc.subjectInternal medicine
dc.subjectBiochemistry
dc.subjectReceptor
dc.subject.sdg3
dc.titleEditorial: Multi-targeted tyrosine kinase inhibitors in the treatment of cancer and neurodegenerative disorders
dc.typeeditorial
dspace.entity.typePublication
local.authorid.openalexA5040352588

Dosyalar

Koleksiyonlar

Publications